Ludwig Boltzmann Gesellschaft
11
1
1
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
9.1%
1 terminated/withdrawn out of 11 trials
83.3%
-3.2% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
I-WEAR: Evaluating Wearables and Health Summaries in ICU Survivors
Role: lead
Polytrauma and Resuscitation Impact on Innate Immunity
Role: lead
Extracorporal Shock Wave Treatment to Improve Nerve Regeneration
Role: lead
The Effectiveness of a Serious Game Targeting Interpersonal Emotion Regulation in Early Adolescents
Role: collaborator
Early Mobilization of Operatively Stabilized Distal Radius Fractures - a Randomized Controlled Trail
Role: lead
Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography
Role: collaborator
Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography
Role: collaborator
Professionals' Perspectives on Facilitating and Hindering Factors of Implementing Health Promotion Programs in Organizational Settings
Role: lead
Noninvasive Measurement of Cardiac Output in Pulmonary Hypertension Using Inert Gas Rebreathing
Role: collaborator
Effects of Donepezil on Deficits Associated With Age-Related Decrease of Growth Hormone
Role: lead
Prophylactic Use of Levosimendan Versus Milrinone in Open Heart Surgery in Infants
Role: lead
All 11 trials loaded